v3.26.1
Note 17 - Related Parties (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Dec. 31, 2025
Jun. 02, 2025
Jan. 29, 2025
Jan. 06, 2025
Oct. 28, 2024
Oct. 25, 2024
Sep. 03, 2024
May 01, 2024
Jan. 09, 2023
Apr. 30, 2025
Dec. 31, 2025
Jul. 11, 2025
Jun. 20, 2025
Feb. 28, 2025
Dec. 31, 2024
Aug. 23, 2024
Aug. 22, 2024
Jul. 25, 2024
May 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)   13,154                                  
Class of Warrant or Right, Issued in Period (in shares)                     579,098                
Class of Warrant or Right, Exercised in Period (in shares)                     162,947                
Cardionomix Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent 82.00%                   82.00%     82.00%          
KardioNav, Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent 57.00%                   57.00%   57.00%            
KardioNav, Inc. [Member] | Chelak iECG, Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                         33.00%            
Series M Warrants [Member]                                      
Class of Warrant or Right, Issued in Period (in shares) 340,000                                    
Warrants and Rights Outstanding $ 509,000                   $ 509,000                
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) $ 1.56                   $ 1.56                
Series H Warrants [Member]                                      
Class of Warrant or Right, Exercised in Period (in shares)           104,737                          
Series I Warrants [Member]                                      
Class of Warrant or Right, Exercised in Period (in shares)           122,368                          
Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                     26,315                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)   1,315                                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares) 26,315                   26,315       1,315        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share) $ 10.07                   $ 10.07       $ 101.1        
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)                     $ 10.07                
Share-Based Payment Arrangement, Option [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                     160,360                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares) 123,678                   123,678       3,701        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share) $ 8.07                   $ 8.07       $ 88.72        
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)                     $ 6.34                
Chief Commercial Officer [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     13,154         1,315                      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)     $ 7.98         $ 101.1                      
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     1,315                                
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)     4 years                                
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     1,315                                
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage               20.00%                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)               5 years                      
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)     1,644                                
Chief Financial Officer [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)       26,315                              
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)       $ 10.07                              
Chief Financial Officer [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)       $ 10.07                              
Chief Financial Officer [Member] | Share-Based Payment Arrangement, Option [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)       36 months                              
Chief Financial Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Non-plan Options [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)       3 years                              
Old Catheter [Member] | Mr. Jenkins and Affiliates [Member]                                      
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                     1,325.838                
Old Catheter [Member] | Mr. Jenkins Adult Children [Member]                                      
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                     1,284.344                
Conversion of Royalties Payable into Series J Preferred Stock [Member] | Inventor of LockeT [Member]                                      
Conversion of Stock, Shares Issued (in shares) 9,490                                    
LockeT Royalty [Member] | Inventor of LockeT [Member]                                      
Royalty Percentage                   5.00%                  
Royalty Guarantees, Commitments, Amount                   $ 1,000,000                  
LockeT Royalty [Member] | Royalty Payment After U.S. Patent Granted and One Million Paid [Member] | Inventor of LockeT [Member]                                      
Royalty Percentage                 2.00%                    
Royalty Guarantees, Commitments, Amount                   10,000,000                  
David Jenkins [Member]                                      
Convertible Notes Payable                 $ 25,100,000                    
Interest Accrued and Unpaid, Forgiven Amount                 $ 13,900,000                    
David Jenkins [Member] | LockeT Royalty [Member]                                      
Royalty Percentage                 12.00%                    
David Jenkins [Member] | Conversion of Convertible Promissory Notes into Series X Preferred Stock [Member]                                      
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)                 7,856.251                    
Auston Locke [Member] | LockeT Royalty [Member]                                      
Royalty Percentage                 5.00%                    
Royalty Guarantees, Commitments, Amount                 $ 1,000,000 $ 1,000,000                  
Auston Locke [Member] | LockeT Royalty [Member] | Royalty Payment After U.S. Patent Granted and One Million Paid [Member]                                      
Royalty Percentage                   5.00%                  
Royalty Guarantees, Commitments, Amount                   $ 10,000,000                  
Increase in Royalty Percentage                   2.00%                  
Non-Executive Chief Operating Officer [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                     757                
Non-Executive Chief Operating Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period (in shares)                     17                
Non-Executive Chief Operating Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]                                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number (in shares) 740                   740                
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in dollars per share) $ 112.1                   $ 112.1                
Related Party [Member] | Related Party Notes [Member]                                      
Debt Instrument, Interest Rate, Stated Percentage                       4.20%       12.00% 8.00%    
Debt Instrument, Face Amount                       $ 150,000              
Related Party [Member] | Related Party Notes [Member] | Series M Warrants [Member]                                      
Class of Warrant or Right, Issued in Period (in shares) 170,000                                    
Jenkins Family Charitable Institute [Member]                                      
Debt Instrument, Face Amount $ 500,000                   $ 500,000                
Proceeds from Issuance Initial Public Offering             $ 500,000                        
Stock Issued During Period, Shares, New Issues (in shares)             13,947                        
Jenkins Family Charitable Institute [Member] | Prefunded Warrants [Member]                                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             12,368                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 0.0019                        
Class of Warrant or Right, Exercised in Period (in shares)         12,368                            
Stock Issued During Period, Shares, Warrant Exercises (in shares)         12,368                            
Jenkins Family Charitable Institute [Member] | Series H Warrants [Member]                                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             26,316                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 19                        
Jenkins Family Charitable Institute [Member] | Series I Warrants [Member]                                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             26,316                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 19                        
Jenkins Family Charitable Institute [Member] | Series J Warrants [Member]                                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)             26,316                        
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)             $ 19                        
Class of Warrant or Right, Distributed (in shares)         23,684                            
Jenkins Family Charitable Institute [Member] | Related Party Notes [Member]                                      
Debt Instrument, Face Amount                                   $ 500,000  
Mr. Jenkins [Member]                                      
Debt Instrument, Face Amount $ 500,000                   $ 500,000                
Mr. Jenkins [Member] | Cardionomix Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                         3.00% 5.00%          
Mr. Jenkins [Member] | Related Party Notes [Member]                                      
Debt Instrument, Face Amount                                     $ 500,000
Mr. Jenkins and Affiliates [Member] | Cardionomix Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                         7.00% 7.00%          
Certain Third Parties [Member] | Cardionomix Inc. [Member]                                      
Subsidiary, Ownership Percentage, Parent                           6.00%